22157.jpg
China Lenalidomide Markets, 2016-2020 & 2021-2025: Sales Value was CNY297.4 Million in 2020 and the CAGR of Lenalidomide from 2016 to 2020 is 98.7%
May 11, 2021 05:23 ET | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Lenalidomide Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Lenalidomide is an oral...
22157.jpg
China Aflibercept Market Report 2021-2025 Featuring Bayer & Regeneron
May 11, 2021 05:18 ET | Research and Markets
Dublin, May 11, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Aflibercept Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Aflibercept is an anti-VEGF...